Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-09

Clinical Trial Update: HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating hepatic arterial infusion chemotherapy (HAIC) versus transarterial chemoembolization (TACE) for large unresectable hepatocellular car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepatic Arterial Infusion Chemotherapy
  • Transarterial chemoembolization (chemotherapy with embolization (various agents))

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED